Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-03

FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Aurobindo Pharma Limited, updating the regulatory status for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)